Olfr851, an olfactory receptor found in Mus musculus (house mouse), plays a pivotal role in the sensory perception of odors. As a member of the olfactory receptor family, Olfr851 is part of a vast group of G-protein-coupled receptors (GPCRs) characterized by a seven-transmembrane domain structure. These receptors are essential for detecting and transducing odorant signals, initiating neuronal responses that lead to the perception of different smells. The olfactory receptor gene family represents the largest gene family in the mouse genome, and its nomenclature is unique to this organism. Inhibition of Olfr851 can be achieved through various mechanisms involving chemicals that target specific pathways or processes associated with olfaction. While some chemicals may directly interact with Olfr851, others exert their effects indirectly by modulating components of the olfactory signal transduction pathway. For example, compounds like Isoflurane and Lidocaine can indirectly influence Olfr851 by altering neuronal excitability within the olfactory system, thereby impacting the detection and perception of odorants. Propanolol, a beta-blocker, may indirectly inhibit Olfr851 by reducing sympathetic nervous system activity, affecting olfactory signal transduction.
Chemicals like Zinc Sulfate and Nifedipine can potentially influence Olfr851 by modulating zinc-dependent and calcium-dependent processes, respectively, within the olfactory system. These alterations in ion balance and signaling pathways can disrupt the normal functioning of Olfr851 and other olfactory receptors, leading to changes in olfaction. Other compounds like Caffeine and Atropine may indirectly affect Olfr851 by modulating neurotransmitter balance and cholinergic signaling, impacting the olfactory system and receptor function. Additionally, compounds such as Iodoacetamide, Alpha-Bungarotoxin, Tetrodotoxin, 2-Aminoethyl diphenylborinate, and Amiloride offer potential strategies for Olfr851 inhibition by targeting specific molecular mechanisms within the olfactory system. These inhibitors collectively provide insights into the complex interplay of molecular and cellular processes involved in olfaction. In conclusion, Olfr851 serves as a key player in the sensory perception of odors, and its inhibition can be achieved through various chemical mechanisms. These inhibitors offer valuable tools for studying the function of Olfr851 and the broader olfactory receptor family, shedding light on the intricate processes underlying the sense of smell in the house mouse.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Isoflurane | 26675-46-7 | sc-470926 sc-470926A | 5 g 25 g | $69.00 $219.00 | 7 | |
Isoflurane is a volatile anesthetic that can potentially inhibit Olfr851 by modulating neuronal excitability in the olfactory system, affecting the perception of odorants and interrupting the normal olfaction process. | ||||||
Propranolol | 525-66-6 | sc-507425 | 100 mg | $180.00 | ||
Propanolol is a beta-blocker that may indirectly inhibit Olfr851 by reducing sympathetic nervous system activity. This can influence olfactory signal transduction and perception, impacting the function of olfactory receptors. | ||||||
Zinc | 7440-66-6 | sc-213177 | 100 g | $48.00 | ||
Zinc Sulfate can potentially affect Olfr851 by modulating zinc-dependent signaling pathways in the olfactory system. Zinc is known to influence olfactory receptors, and alterations in zinc levels can impact olfaction. | ||||||
Nifedipine | 21829-25-4 | sc-3589 sc-3589A | 1 g 5 g | $59.00 $173.00 | 15 | |
Nifedipine is a calcium channel blocker that may indirectly inhibit Olfr851 by affecting calcium-dependent processes in olfactory signal transduction. Alterations in calcium levels can disrupt the function of olfactory receptors. | ||||||
Caffeine | 58-08-2 | sc-202514 sc-202514A sc-202514B sc-202514C sc-202514D | 50 g 100 g 250 g 1 kg 5 kg | $33.00 $67.00 $97.00 $192.00 $775.00 | 13 | |
Caffeine can potentially interfere with Olfr851 by modulating adenosine receptors in the olfactory system. As a stimulant, caffeine may affect neurotransmitter balance, leading to alterations in olfactory perception. | ||||||
Atropine | 51-55-8 | sc-252392 | 5 g | $204.00 | 2 | |
Atropine is a muscarinic receptor antagonist that can potentially influence Olfr851 indirectly by blocking acetylcholine signaling. This blockade may disrupt the normal function of olfactory receptors and perception of odorants. | ||||||
Lidocaine | 137-58-6 | sc-204056 sc-204056A | 50 mg 1 g | $51.00 $131.00 | ||
Lidocaine is a local anesthetic that may affect Olfr851 by interfering with neuronal excitability in the olfactory system. This can lead to reduced sensitivity to odorants and inhibition of olfactory receptor function. | ||||||
α-Iodoacetamide | 144-48-9 | sc-203320 | 25 g | $255.00 | 1 | |
Iodoacetamide is a sulfhydryl-reactive compound that can potentially inhibit Olfr851 by modifying cysteine residues in olfactory receptors or associated proteins, disrupting the normal olfactory signal transduction pathway. | ||||||
α-Bungarotoxin | 11032-79-4 | sc-202897 | 1 mg | $351.00 | 5 | |
Alpha-Bungarotoxin is a competitive antagonist of nicotinic acetylcholine receptors. It may indirectly affect Olfr851 by interfering with cholinergic signaling, leading to alterations in the olfactory system and receptor function. | ||||||
2-APB | 524-95-8 | sc-201487 sc-201487A | 20 mg 100 mg | $28.00 $53.00 | 37 | |
2-Aminoethyl diphenylborinate is known to modulate intracellular calcium levels. It may potentially influence Olfr851 indirectly by altering calcium-dependent processes in olfactory signal transduction, affecting receptor function. | ||||||